Logo
Meet Pharmidex at KTN 2016
June 14, 2016

Collaboration opportunities in regenerative medicine

Pharmdiex will be attending the Innvoate UK KTN 2016 meeting focused on New Collaboration Opportunities in Regenerative Medicine.

The KTN in collaboration with Innovate UK, Cell and Gene Therapy Catapult, Department of Health and Kings College London are holding an event focussing on new unmet clinical needs, latest developments in regulatory environment and clinical adoption. Following recent developments and the UK’s Regenerative Medicine Expert Group report recommendations, this event will bring together the UK regenerative medicine communities involving industrialists, academics and clinicians from a number of clinical specialities.


The UK is leading the field in the development of cell and gene therapies. The regulatory system now has a number of mechanisms to accelerate the progress of promising therapies including EAMS and the proposed new PRIME scheme. However, practical challenges still exist to the clinical adoption of these new therapies and getting them to patients, including generating sufficient clinical data, achieving reimbursement and embedding therapies in existing or new clinical pathways).


Leading clinicians and experts from a number of organisations will be presenting at this event. Directors and managers from major funding organisations, e.g. Innovate UK, Research Councils, relevant charities will also be invited to support this event.


The main aims of this event are as follows;


  • To discuss challenges affecting clinical adoption of cell and gene-based therapies.
  • Facilitate new clinician/industry collaborations in a number of areas of clinical specialities.
  • Identify barriers to innovation and commercialisation.
  • Review current funding opportunities and identify funding gaps.
  • Provide networking opportunities to identify collaborating partners.
  • Review supporting mechanisms available to accelerate innovation and commercialisation through KTN and partners Innovate UK, Cell and Gene Therapy Catapult organisations.
  • Review current pre-clinical and clinical trials and identify best practice to accelerate regulatory approvals


For more information please see the following link: https://www.eventbrite.co.uk/e/new-collaboration-opportunities-in-regenerative-medicine-tickets-24454460951

February 18, 2025
We’re thrilled to offer Haematology Services to advance drug development and research. Our lab features, the Siemens analyser, delivering precise results across key biological parameters. 🔬 Services Include: Full Blood Count (FBC) Reticulocytes Differential Analysis 🐾 Supporting human and animal models 💡 Applications: Diagnose blood disorders (anaemia, leukaemia and others). Evaluate treatment efficacy in preclinical models. Translate findings from animals to humans. 📦 Sample Details: Minimum 200 µL of EDTA whole blood. Reach out today to learn how we can support your research!
February 13, 2025
We had great fun networking, supporting wellbeing, nurturing our community and raising money for Stevenage based STEMPOINT , the educational charity dedicated to widening access into science, engineering, maths and technology subjects across EastAnglia. Over 30 players took part in the cross-campus sports event, we welcomed teams from GSK, ImmuONE, Tessellate BIO, Neobe Therapeutics, Stevenage Bioscience Catalyst, Pharmidex , MFX, Antikor Biopharma Ltd – and of course STEMPOINT - who came to join us. Congratulations goes to Ash Alavijeh from Pharmidex who won best player of the rally! See you all again in the next badminton tournament in the Spring!
OBN Science Social
February 12, 2025
Pharmidex at OBN Science Social
More Posts
Share by: